Journal of the International AIDS Society

Article	Citations
Understanding adaptive responses in PrEP service delivery in Belgian HIV clinics: a multiple case study using an implementation science framework	116
Sustaining the HIV/AIDS response: PEPFAR's vision	67
HIV Glasgow, 23–26 October 2022, Glasgow, UK / Virtual	65
Systematic review and meta‐analysis of retention and disengagement after initiation on antiretroviral therapy in low‐ and middle‐income countries after the introduction of Universal Test and Treat pol	64
Effects of Stop‐Work orders on HIV testing, treatment and programmes for prevention of vertical transmission in four sub‐Saharan African countries	62
“If they had a place to live, they would be taking medication”: a qualitative study identifying strategies for engaging street‐connected young people in the HIV prevention‐care continuum in Ken	54
Population‐level analysis of natural control of HIV infection in Zambia and South Africa: HPTN 071 (PopART)	48
Exploring potential drug−drug interactions between masculinizing hormone therapy and oral pre‐exposure prophylaxis (F/TDF and F/TAF) among transgender men (iMACT study): a randomized, open‐label pharm	48
Counselling behavioural interventions for HIV, STI and viral hepatitis among key populations: a systematic review of effectiveness, values and preferences, and cost studies	44
When and how to intervene to improve the health of children born HIV‐free	39
Third‐line antiretroviral therapy, including raltegravir (RAL), darunavir (DRV/r) and/or etravirine (ETR), is well tolerated and achieves durable virologic suppression over 144 weeks in resource‐limit	39
Do not forget the children: a model‐based analysis on the potential impact of COVID‐19‐associated interruptions in paediatric HIV prevention and care	38
The effect of tracer contact on return to care among adult, “lost to follow‐up” patients living with HIV in Zambia: an instrumental variable analysis	38
Effectiveness and safety of tenofovir alafenamide in children and adolescents living with HIV: a systematic review	36
Adherence challenges with daily oral pre‐exposure prophylaxis during pregnancy and the postpartum period in South African women: a cohort study	35
	35
	34
A cross‐sectional assessment of injection of “salts” and HIV transmission‐related behaviours among a cohort of people who inject drugs in Kyrgyzstan	32
Community‐led monitoring: a voice for key populations in Zimbabwe	32
Leveraging HIV self‐testing to achieve the UNAIDS 2025 targets in the South and Southeast Asia region	32
	32
Effectiveness of HIV self‐testing when offered within assisted partner services in Western Kenya (APS‐HIVST Study): a cluster randomized controlled trial	31
Issue Information	31
India's adaptation of HIV services to ensure continuity of service delivery during the COVID‐19 pandemic	31
A cross‐sectional study evaluating the frequency of HIV drug resistance mutations among individuals diagnosed with HIV‐1 in tenofovir disoproxil fumarate‐based pre‐exposure prophylaxis rollout program	30

Contents	30
Experiences of oral pre‐exposure prophylaxis use among heterosexual men accessing sexual and reproductive health services in South Africa: a qualitative study	30
Issue Information	30
Patterns of daily oral HIV PrEP adherence among people who inject drugs in Ukraine: an analysis of biomarkers	30
Differentiating the incidence and burden of HIV by age among women who sell sex: a systematic review and meta‐analysis	28
Socio‐economic status and adherence to HIV preventive and therapeutic interventions: exploring the mediating role of food insecurity among men who have sex with men and transgender and non‐binary pers	28
The lavender purge	28
Patterns of person‐centred communications in public HIV clinics: a latent class analysis using the Roter interaction analysis system	28
Issue Information	28
Managers’ and providers’ perspectives on barriers and facilitators for the implementation of differentiated service delivery models for HIV treatment in Mozambique: a qualitative study	27
Ageing with HIV: a longitudinal study of markers of resilience in young adults with perinatal exposure to HIV, with or without perinatally acquired HIV	27
Using community conversations to integrate violence screening and referrals into HIV care for young women living with HIV in Lusaka, Zambia	27
Empowering at‐risk Thai adolescents and young adults: an observational study of “Stand By You” – a person‐centred online service model for HIV self‐screening, text‐based counselling and linkage to car	26
Breaking down relationship barriers to increase PrEP uptake and adherence among adolescent girls and young women in Kenya: safety and preliminary effectiveness results from a pilot cluster‐randomized	26
A phase 1, open‐label study to evaluate the drug interaction between islatravir (MK‐8591) and the oral contraceptive levonorgestrel/ethinyl estradiol in healthy adult females	24
Contraceptive implant use duration is not associated with breakthrough pregnancy among women living with HIV and using efavirenz: a retrospective, longitudinal analysis	23
Achieving equity for children and adolescents with perinatal HIV exposure: an urgent need for a paradigm shift	23
	22
Feasibility and acceptability of peer‐delivered HIV and syphilis self‐test kits and assisted partner notification services for gay, bisexual and other men who have sex with men: a qualitative study in	22
Trajectories of PrEP use among men who have sex with men: a pooled analysis of two prospective, observational cohort studies	21
Contents	21
	21
Systematic review of the values and preferences regarding the use of injectable pre‐exposure prophylaxis to prevent HIV acquisition	21
Using FRAME to characterize provider‐identified adaptations to a stepped care intervention for adolescents and youth living with HIV in Kenya: a mixed methods approach	21
Prevalence of sexualized drug use and risk of HIV among sexually active MSM in East and South Asian countries: systematic review and meta‐analysis	21
Adaptation and psychometric evaluation of a scale to measure oral pre‐exposure prophylaxis‐related stigma among key and vulnerable populations in Kenya	20
Implementation strategies to improve HIV care cascade outcomes in low‐ and middle‐income countries: a systematic review from 2014 to 2021	20
ChemsexPH: The association between chemsex, HIV status and adherence to antiretroviral therapy among men who have sex with men in the Philippines	20
Sarcopenia in people living with HIV in Hong Kong: which definition correlates with health outcomes?	20
Injection network drivers of HIV prevention service utilization among people who inject drugs: results of a community‐based sociometric network cohort in New Delhi, India	20
Healthcare provisions associated with multiple HIV‐related outcomes among adolescent girls and young women living with HIV in South Africa: a cross‐sectional study	20
Monitoring adherence to antiretroviral therapy among adolescents in Southern Uganda: comparing Wisepill to Self‐report in predicting viral suppression in a cluster‐randomized trial	20
Preferences for TB treatment and support delivery models among people living with TB in Eastern Cape, South Africa: a discrete choice experiment	19
	19
Impact of the COVID‐19 pandemic on TB services at ART programmes in low‐ and middle‐income countries: a multi‐cohort survey	19
Improving PrEP access for adolescent girls and young women: a descriptive analysis of community‐based PrEP delivery in the DREAMS programme in Zambia	19
Issue Information	19
Feasibility and acceptability of persons on long‐acting cabotegravir for HIV prevention in the SEARCH Dynamic Choice HIV Prevention trial extension in rural Kenya and Uganda: a longitudinal cohort stu	19
Impart: findings from a prison‐based model of HIV assisted partner notification in Indonesia	19
Issue Information	19
AUTHOR INDEX	18
Factors associated with mobile app‐based ordering of HIV self‐test kits among men who have sex with men in Atlanta, Detroit and New York City: an exploratory secondary analysis of a randomized control	18
	18
“It gives me the strength and courage to take care of myself”: a qualitative exploration of experiences with STI testing among women who initiated PrEP during pregnancy in Western Kenya	18
Incident HIV acquisition among pregnant women in Botswana: findings from the Tsepamo birth outcomes surveillance study	18
Sexual and drug use risk behaviour trajectories among people treated for recent HCV infection: the REACT study	18
Methodological issues in the designing and reporting of frequentist and Bayesian meta‐analysis to assess COVID‐19 outcomes among PLHIV with various comorbidities	18
Clients in Uganda accessing preferred differentiated antiretroviral therapy models achieve higher viral suppression and are less likely to miss appointments: a cross‐sectional analysis	18
Ethical HIV research with transgender and non‐binary communities in the United States	17
Lessons learned from community engagement regarding phylodynamic research with molecular HIV surveillance data	17

Client experiences with “Dynamic Choice Prevention,” a model for flexible patient‐centred HIV prevention delivery in rural Eastern Africa	17
COVID‐19 among adults living with HIV: correlates of mortality among public sector healthcare users in Western Cape, South Africa	17
Caring for the whole person: transgender‐competent HIV pre‐exposure prophylaxis as part of integrated primary healthcare services in Vietnam	17
What can we learn from HIV, COVID‐19 and mpox stigma to guide stigma‐informed pandemic preparedness?	17
A one‐stop shop model for improved efficiency of pre‐exposure prophylaxis delivery in public clinics in western Kenya: a mixed methods implementation science study	17
Community contexts and knowledge: accountability, leadership and meaningful involvement of communities in Programme Science	16
Certification of lay providers to deliver key population‐led HIV services in Thailand's National Healthcare System: lessons learned	16
Abstract Supplement HIV Glasgow 10–13 November 2024, Glasgow, UK/Virtual	16
The impact of prevention‐effective PrEP use on HIV incidence: a mathematical modelling study	16
Providing differentiated service delivery to the ageing population of people living with HIV	16
Cost‐Effectiveness and Budget Impact Analysis of the Implementation of Differentiated Service Delivery Models for HIV Treatment in Mozambique: a Modelling Study	16
Preparing for long‐acting PrEP delivery: building on lessons from oral PrEP	16
The role of internalised HIV stigma in disclosure of maternal HIV serostatus to children perinatally HIV‐exposed but uninfected: a prospective study in the United States	15
Improving access to integrated community‐based HIV, HCV and harm reduction services for people who inject drugs in Putao district, North Myanmar	15
Lessons from the field: understanding the use of a youth tailored U = U tool by peer educators in Lesotho with adolescents and youth living with HIV	15
Assessing the HIV care continuum among transgender women during 11 years of follow‐up: results from the Netherlands’ ATHENA observational cohort	15
Shaping and coordinating the implementation science agenda for injectable cabotegravir for PrEP: the role of the Biomedical Prevention Implementation Collaborative (BioPIC)	15
HIV‐1 drug resistance among individuals who seroconverted in the ASPIRE dapivirine ring trial	15
Experiences, perceptions and potential impact of community‐based mentor mothers supporting pregnant and postpartum women with HIV in Kenya: a mixed‐methods study	15
Fostering citizen‐engaged HIV implementation science	15
Finally, PrEP choices! But will clients ever have a choice?	14
	14
	14
Advanced disease programming brings much needed attention and improvements to inpatient paediatric HIV care in Mozambique	14
Costs and cost‐effectiveness of a collaborative data‐to‐care intervention for HIV treatment and care in the United States	14
Use of quality‐of‐life instruments for people living with HIV: a global systematic review and meta‐analysis	14
Sex modifies the association between HIV and coronary artery disease among older adults in Uganda	14
Evidence from high‐income countries on the effectiveness of psychosocial interventions to improve mental health, wellbeing and quality of life for adults living with HIV: a systematic review and meta‐	14
HIV disclosure and depressive symptoms among pregnant women living with HIV: a cross‐sectional study in the Democratic Republic of Congo	14
Cost‐effectiveness of hepatitis C virus test‐and‐treat and risk reduction strategies among men who have sex with men living with HIV in France	14
HIV knowledge and access to testing for people with and without disabilities in low‐ and middle‐income countries: evidence from 37 Multiple Indicator Cluster Surveys	14
To effectively reduce violence against women living with HIV, we must make healthcare systems places of safety	14
Examining barriers to antiretroviral therapy initiation in infants living with HIV in sub‐Saharan Africa despite the availability of point‐of‐care diagnostic testing: a narrative systematic review	13
Issue Information	13
Ensuring impact of long‐acting HIV therapeutics through multi‐level treatment research: a view from NIH	13
A prospective cohort study of the SEARCH integrated HIV/hypertension community health worker‐led intervention in rural Kenya and Uganda	13
Weight gain during the dolutegravir transition in the African Cohort Study	13
REPRIEVE final results: What does it mean for guidelines in low‐ and middle‐income countries?	13
HIV incidence and prevalence among adults in Mozambique: estimates from the Population‐based HIV Impact Assessment Survey (INSIDA 2021) and district‐level modelling	13
High acceptability, feasibility and sustainability of a direct‐to‐pharmacy differentiated PrEP delivery model in public health HIV clinics in Kenya: perspectives of PrEP clients and healthcare provide	13
Implementation research and the HIV response: Taking stock and charting the way forward	13
Issue Information	13
Implementation and resource needs for long‐acting PrEP in low‐ and middle‐income countries: a scoping review	13
Antiretroviral drug exposure in lymph nodes is heterogeneous and drug dependent	12
Health‐related needs reported by adolescents living with HIV and receiving antiretroviral therapy in sub‐Saharan Africa: a systematic literature review	12
	12
A thank you note to our peer reviewers (2024)	12
Characterizing adolescent and youth‐friendly HIV services: a cross‐sectional assessment across 16 global sites	12
Improving ART initiation among men who use HIV self‐testing in Malawi: a qualitative study	12
Issue Information	12
South African healthcare workers’ knowledge of dolutegravir's drug–drug interactions in the first year of its rollout: a cross‐sectional online survey	12
	12
Occupational post‐exposure prophylaxis among healthcare workers: a scoping review of factors affecting optimal utilization	11
Aligning HIV treatment and hypertension clinic visits and dispensing as a first step towards service delivery integration in South Africa	11
Providing HIV‐assisted partner services to partners of partners in western Kenya: an implementation science study	11
Early structural brain development in infants exposed to HIV and antiretroviral therapy in utero in a South African birth cohort	11
Prevalence and co‐occurrence of symptoms of mental and substance use disorders among people with HIV age 40 and older in low‐ and middle‐income countries: a cross‐sectional study	11
HIV pre‐exposure prophylaxis programme preferences among sexually active HIV‐negative transgender and gender diverse adults in the United States: a conjoint analysis	11
Being yourself is a defect: analysis of documented rights violations related to sexual orientation, gender identity and HIV in 2022 using the REAct system in six eastern European, Caucasus and Central	11
An evaluation of nine culturally tailored interventions designed to enhance engagement in HIV care among transgender women of colour in the United States	11
Antiretroviral postnatal prophylaxis to prevent HIV vertical transmission: present and future strategies	11
The effectiveness, feasibility and acceptability of HIV service delivery at private pharmacies in sub‐Saharan Africa: a scoping review	11
The ethics of exclusion: why pregnant and lactating women must be front and centre of HIV research	11
Non‐clinical considerations for supporting accelerated inclusion of pregnant women in pre‐licensure clinical trials with anti‐HIV agents	11
Preferences for models of sexual health service delivery among gay, bisexual and other men who have sex with men in Australia: a discrete choice experiment	11
Differences in clinical characteristics between adolescents and young adults with perinatally and sexually acquired HIV in the Asia‐Pacific region	11
Prevalence of cardiovascular risk factors by HIV status in a population‐based cohort in South Central Uganda: a cross‐sectional survey	11
Abstract Supplement Abstracts from IAS 2023, the 12th IAS Conference on HIV Science, 23 – 26 July, Brisbane, Australia & Virtual	11
Population‐level effectiveness of pre‐exposure prophylaxis for HIV prevention among men who have sex with men in Montréal (Canada): a modelling study of surveillance and survey data	10
Person‐centred HIV prevention in an era of innovation and uncertainties	10
	10
A conjoint experiment of three placebo rectal products used with receptive anal sex: results from MTN‐035	10
Put rights at the centre of person‐ and people‐centred HIV prevention	10
Bringing together the pieces: the need for holistic care for women with HIV	10
Knowledge as resistance: advancing global health in challenging times	10
Awareness and intention to use event‐driven and long‐acting injectable pre‐exposure prophylaxis among adolescent and young men who have sex with men and transgender women in Brazil: a cross‐sectional	10
Low PrEP adherence despite high retention among transgender women in Brazil: the PrEParadas study	10
	10
PrEP awareness and protective barrier negotiation among transgender people attracted to men in Aotearoa New Zealand	10
AUTHOR INDEX	10

The effect of STI screening during pregnancy on vertical transmission of HIV and adverse pregnancy outcomes in South Africa: a modelling study	10
Failing to learn the lessons: the U.S. response on global health security ignores 20 years of PEPFAR	10
AUTHOR INDEX	10
	10
Long‐acting injectable ART to advance health equity: a descriptive analysis of US clinic perspectives on barriers, needed support and programme goals for implementation from applications to the ALAI U	10
The power of one – in memoriam of Paul E. Farmer	10
AUTHOR INDEX	10
Issue Information	10
Including transgender populations in mathematical models for HIV treatment and prevention: current barriers and policy implications	10
Characteristics of individuals who received post‐exposure prophylaxis and HIV seroconversion in Malawi: an analysis of national routine HIV testing data	9
AUTHOR INDEX	9
High peak viraemia followed by spontaneous HIV‐1 control in women living with HIV‐1 subtype A1 in East Africa	9
Comorbidities and HIV‐related factors associated with mental health symptoms and unhealthy substance use among older adults living with HIV in low‐ and middle‐income countries: a cross‐sectional study	9
Person‐centred, integrated non‐communicable disease and HIV decentralized drug distribution in Eswatini and South Africa: outcomes and challenges	9
“People have options”: a qualitative study of experiences and influences of PrEP choice among women in South Africa	9
Treatment‐naïve people living with HIV aged 50 years or older in Beijing, China, 2010–2020: joinpoint regression model analysis of surveillance data	9
Prevalence, correlates and solutions to people with HIV in China being refused treatment for diseases not related to HIV: a mixed‐methods study	9
Issue Information	9
Untapped potential of post‐exposure prophylaxis in sub‐Saharan Africa: a comparative analysis of PEP implementation planning in Kenya, Mozambique, Nigeria, Uganda and Zambia	9
Non‐communicable disease (NCD) risk among people living with HIV in KwaZulu‐Natal, South Africa: evidence from a randomised trial of community‐based differentiated service delivery	9
	9
Addressing stigma and discrimination at scale: uniting for a common vision while acknowledging local realities	9
Oral pre‐exposure prophylaxis preference, uptake, adherence and continuation among adolescent girls and young women in Kampala, Uganda: a prospective cohort study	9
Pre‐exposure prophylaxis in real life: experience from a prospective, observational and demonstration project among men who have sex with men in Benin, West Africa	9
Co‐trimoxazole prophylaxis for children who are HIV‐exposed and uninfected: a systematic review	9
	9
Very high HIV prevalence and incidence among men who have sex with men and transgender women in Indonesia: a retrospective observational cohort study in Bali and Jakarta, 2017–2020	9
	9
A citizen science approach to develop a digital intervention to reduce HIV stigma and promote HIV self‐testing among adolescents and young adults: a mixed methods analysis from Kazakhstan	9
Recognizing and disrupting stigma in implementation of HIV prevention and care: a call to research and action	9
HIV prevention programme with young women who sell sex in Mombasa, Kenya: learnings for scale‐up	9
Seizing the moment: the potential of PrEP choice and innovation to transform HIV prevention	9
Projection of age of individuals living with HIV and time since ART initiation in 2030: estimates for France	9
Programme science methodologies and practices that address “FURRIE” challenges: examples from the field	9
Issue Information	9
HIV vaccines in 2022: where to from here?	8
Transforming PrEP marketing: understanding the place of PrEP in the hearts and minds of adolescent girls and young women in sub‐Saharan Africa	8
Preferences for long‐acting pre‐exposure prophylaxis among gay, bisexual and other men who have sex with men in Taiwan: findings from the 2021 HEART Survey	8
How a menu of adherence support strategies facilitated high adherence to HIV prevention products among adolescent girls and young women in sub‐Saharan Africa: a mixed methods analysis	8
Sustaining HIV service delivery to key population clients using client‐centered models during the debate and enactment of the Anti‐Homosexuality Act in Uganda	8
	8
Retraction:	8
HIV awareness and prevention strategies among transgender women in the Eastern and Southern United States: findings from the LITE Study	8
Exploring perceptions and preferences for PrEP choice and of an mHealth intervention: insights from the ImPrEP CAB‐Brasil study	8
The science at HIVR4P 2024: The era of choice in biomedical HIV prevention	8
Excess mortality attributable to AIDS among people living with HIV in high‐income countries: a systematic review and meta‐analysis	8
Issue Information	8
Adults with perinatally acquired HIV in low‐ and middle‐income settings: time for a generational shift in HIV care and global guidance	8
New tricks for an old dog: opportunities for better tuberculosis control	8
	8
Beating the odds: medicines alone will not stop HIV	8
Implementation of long‐acting cabotegravir and rilpivirine: primary results from the perspective of staff study participants in the Cabotegravir And Rilpivirine Implementation Study in European Locati	8
Left behind on the path to 90‐90‐90: understanding and responding to HIV among displaced people	8
AUTHOR INDEX	8
Impact of the Anti‐Homosexuality Act on HIV service delivery in Uganda: Evidence from community‐led monitoring	8
PrEP preferences and early acceptability of injectable cabotegravir among pregnant and lactating people in Cape Town, South Africa: findings from the PrEPared to Choose study	8
Predictors of PrEP awareness, PrEP discussion and interest in long‐acting injectable PrEP among Filipina transfeminine adults	8
On the risk of using raw regional data on new HIV infections in France	8
Modelling the impact of CD4 testing on mortality from TB and cryptococcal meningitis among patients with advanced HIV disease in nine countries	8
	8
Iterative hypothesis testing in HIV vaccine research: moving towards success	8
Community‐ and individual‐level correlates of HIV incidence in HPTN 071 (PopART)	8
Hazardous alcohol use and HIV indicators in six African countries: results from the Population‐based HIV Impact Assessments, 2015–2017	8
	8